尊龙Z6官方网站

Recently, Dr. Jing Ji, Chief Medical Officer of Abbisko Therapeutics, was featured on the cover of AsiaInsightsCare magazine as one of "Asia's Most Influential Chief Medical Officers in the Healthcare Industry, 2025." This recognition underscores her outstanding contributions and broad industry influence in the field of oncology, both across Asia and globally.

In the cover story titled "Jing Ji: Lighting the Path Toward Life-Saving Cancer Therapies," AsiaInsightsCare provides a comprehensive review of Dr. Ji's long-standing practice and leadership in drug development and clinical translation, highlighting her professional philosophy of being patient-centered and driven by scientific innovation.

With more than 20 years of experience in the healthcare and pharmaceutical industry, Dr. Ji joined Abbisko Therapeutics in 2021 as Chief Medical Officer. Since then, she has leveraged her deep professional expertise and exceptional leadership to continuously strengthen the company's clinical development capabilities and accelerate the advancement of its core pipeline, supporting Abbisko's evolution from an emerging biotech company into an innovative pharmaceutical company with growing international influence. By building high-caliber clinical and medical teams and driving meaningful progress across multiple key programs, Dr. Ji has not only fulfilled her role as Chief Medical Officer with distinction, but has also brought breakthrough therapeutic options and renewed hope to patients worldwide.

The full article is provided below: